162
Views
2
CrossRef citations to date
0
Altmetric
Articles

The role of monocytes and natural killers’ immunophenotypic subsets in bronchial asthma in children

, MSc, , MD, , MDORCID Icon & , MDORCID Icon
Pages 244-254 | Received 16 Nov 2021, Accepted 12 Feb 2022, Published online: 26 Feb 2022
 

Abstract

Objective: Childhood bronchial asthma (BA) is a globally significant chronic disease with major health consequences. Recently, focus on the role of the innate immune system has been highlighted. Therefore, this study explores the role of circulating monocytes and natural killer (NK) clusters in childhood asthma.

Methods: This case-control study enrolled 50 children with asthma divided equally into severe and mild groups and 26 healthy children. Flow-cytometry analysis was used to identify circulating blood monocytes and natural killers’ subsets. In addition, pulmonary function test (spirometry) for children with asthma was performed.

Results: This study showed significant negative correlations between frequency of total circulating, classical, intermediate, and nonclassical monocytes with ratio of forced expiratory volume/forced vital capacity (FEV1/FVC) (r = −0.637, P < 0.001; r = −0.575, P < 0.001; r = −0.657, P < 0.001; r = −0.329, P = 0.004, respectively). Also, there was significant negative correlations between frequency of total NKs and CD56dim CD16+ NK with FEV1/FVC (r = −0.584, P < 0.001) and (r = −0.579, P < 0.001). Significant predictors of childhood asthma severity were frequencies of total monocytes, total NKs, intermediate monocytes, and CD56dimCD16+ NK.

Conclusion: Finally, we concluded that the FEV1/FVC is linked to aberrations of monocytes’ and natural killers’ immunophenotypic subsets in children with asthma. The frequencies of total monocytes and NK are significant predictors of severity of childhood asthma. The frequencies of CD14high CD16+ intermediate monocytes and CD56dim CD16+ NK cells are the best independent predictors of severity in children with asthma.

Acknowledgements

We are grateful to all the patients who participated in this study.

Declaration of interest

The authors report no conflict of interest

Funding

The authors received no funding.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.